by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersGram Peptides

All Warning Letters

Gram Peptides

Warning LetterOpen

PO Box 9227 Rancho Santa Fe , CA 92067 United StatesIssued Mar 31, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateMar 31, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Gram Peptides
Location: PO Box 9227 Rancho Santa Fe , CA 92067 United States
FEI Number: N/A
Country: United States
Issue Date: March 31, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Unapproved New Drugs Sold Over the Internet

Gram Peptides FDA Warning Letter, March 31, 2026